top of page
The Second of Two One-Year, Multicenter,Open-Label, Repeat-Dose, Phase II SafetyStudies of PrabotulinumtoxinA for theTreatment of Moderate to Severe GlabellarLines in Adult Patients
Z. Paul Lorenc, MD, FACS; Jeffrey M. Adelglass, MD, FACS;
Rui L. Avelar, MD; Leslie Baumann, MD; Kenneth R. Beer, MD;
Joel L. Cohen, MD; S
Skin Tightening With Hyperdilute CaHA: Dilution Practices and Practical Guidance for Clinical Practice
Z. Paul Lorenc, MD, FACS; Jeanette M. Black, MD; Jessie S. Cheung, MD, FAAD; Annie Chiu, MD; Roberta Del Campo, MD; Alan James Durkin,...
bottom of page